ALPHA & OMEGA SEMICONDUCTOR (AOSL) Fundamental Analysis & Valuation

NASDAQ:AOSL • BMG6331P1041

Current stock price

22.67 USD
-0.17 (-0.74%)
Last:

This AOSL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AOSL Profitability Analysis

1.1 Basic Checks

  • In the past year AOSL has reported negative net income.
  • In the past year AOSL had a positive cash flow from operations.
  • In multiple years AOSL reported negative net income over the last 5 years.
  • In the past 5 years AOSL always reported a positive cash flow from operatings.
AOSL Yearly Net Income VS EBIT VS OCF VS FCFAOSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • AOSL has a Return On Assets of -10.30%. This is in the lower half of the industry: AOSL underperforms 73.91% of its industry peers.
  • The Return On Equity of AOSL (-12.61%) is worse than 69.57% of its industry peers.
Industry RankSector Rank
ROA -10.3%
ROE -12.61%
ROIC N/A
ROA(3y)-3.1%
ROA(5y)6.38%
ROE(3y)-3.88%
ROE(5y)11.4%
ROIC(3y)N/A
ROIC(5y)N/A
AOSL Yearly ROA, ROE, ROICAOSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

  • AOSL's Gross Margin of 22.47% is on the low side compared to the rest of the industry. AOSL is outperformed by 76.52% of its industry peers.
  • In the last couple of years the Gross Margin of AOSL has remained more or less at the same level.
  • AOSL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.52%
GM growth 5Y0.92%
AOSL Yearly Profit, Operating, Gross MarginsAOSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

5

2. AOSL Health Analysis

2.1 Basic Checks

  • AOSL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AOSL has been increased compared to 1 year ago.
  • AOSL has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, AOSL has an improved debt to assets ratio.
AOSL Yearly Shares OutstandingAOSL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
AOSL Yearly Total Debt VS Total AssetsAOSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • AOSL has an Altman-Z score of 3.91. This indicates that AOSL is financially healthy and has little risk of bankruptcy at the moment.
  • AOSL has a Altman-Z score (3.91) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that AOSL is not too dependend on debt financing.
  • AOSL has a Debt to Equity ratio of 0.00. This is in the better half of the industry: AOSL outperforms 69.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.91
ROIC/WACCN/A
WACC11.5%
AOSL Yearly LT Debt VS Equity VS FCFAOSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 3.44 indicates that AOSL has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.44, AOSL is in line with its industry, outperforming 59.13% of the companies in the same industry.
  • AOSL has a Quick Ratio of 2.01. This indicates that AOSL is financially healthy and has no problem in meeting its short term obligations.
  • AOSL's Quick ratio of 2.01 is in line compared to the rest of the industry. AOSL outperforms 46.09% of its industry peers.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 2.01
AOSL Yearly Current Assets VS Current LiabilitesAOSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

4

3. AOSL Growth Analysis

3.1 Past

  • The earnings per share for AOSL have decreased strongly by -131.43% in the last year.
  • The earnings per share for AOSL have been decreasing by -24.39% on average. This is quite bad
  • AOSL shows a small growth in Revenue. In the last year, the Revenue has grown by 2.92%.
  • Measured over the past years, AOSL shows a quite strong growth in Revenue. The Revenue has been growing by 8.41% on average per year.
EPS 1Y (TTM)-131.43%
EPS 3Y-63.57%
EPS 5Y-24.39%
EPS Q2Q%-277.78%
Revenue 1Y (TTM)2.92%
Revenue growth 3Y-3.62%
Revenue growth 5Y8.41%
Sales Q2Q%-6.29%

3.2 Future

  • AOSL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.75% yearly.
  • AOSL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.38% yearly.
EPS Next Y-390.55%
EPS Next 2Y-104.81%
EPS Next 3Y66.75%
EPS Next 5YN/A
Revenue Next Year-2.01%
Revenue Next 2Y2.12%
Revenue Next 3Y6.38%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AOSL Yearly Revenue VS EstimatesAOSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
AOSL Yearly EPS VS EstimatesAOSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

1

4. AOSL Valuation Analysis

4.1 Price/Earnings Ratio

  • AOSL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year AOSL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AOSL Price Earnings VS Forward Price EarningsAOSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AOSL is valued a bit cheaper than the industry average as 78.26% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.55
AOSL Per share dataAOSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AOSL's earnings are expected to grow with 66.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-104.81%
EPS Next 3Y66.75%

0

5. AOSL Dividend Analysis

5.1 Amount

  • AOSL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AOSL Fundamentals: All Metrics, Ratios and Statistics

ALPHA & OMEGA SEMICONDUCTOR

NASDAQ:AOSL (4/2/2026, 3:48:40 PM)

22.67

-0.17 (-0.74%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-05
Earnings (Next)05-05
Inst Owners77.22%
Inst Owner Change0.79%
Ins Owners16.45%
Ins Owner Change2.45%
Market Cap674.66M
Revenue(TTM)685.88M
Net Income(TTM)-103.28M
Analysts77.78
Price Target22.44 (-1.01%)
Short Float %6.27%
Short Ratio4.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.32%
Min EPS beat(2)-88.24%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)72.66%
Min EPS beat(4)-88.24%
Max EPS beat(4)296.08%
EPS beat(8)6
Avg EPS beat(8)58.77%
EPS beat(12)9
Avg EPS beat(12)101.76%
EPS beat(16)11
Avg EPS beat(16)75.81%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)-0.99%
Revenue beat(4)2
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)2.65%
Revenue beat(8)2
Avg Revenue beat(8)-0.39%
Revenue beat(12)3
Avg Revenue beat(12)-0.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.67%
PT rev (1m)0%
PT rev (3m)-9.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-176.92%
EPS NY rev (1m)-317.78%
EPS NY rev (3m)-248.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.98
P/FCF N/A
P/OCF 102.16
P/B 0.82
P/tB 0.83
EV/EBITDA 21.55
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.48
Fwd EYN/A
FCF(TTM)-1.39
FCFYN/A
OCF(TTM)0.22
OCFY0.98%
SpS23.05
BVpS27.51
TBVpS27.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.3%
ROE -12.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.47%
FCFM N/A
ROA(3y)-3.1%
ROA(5y)6.38%
ROE(3y)-3.88%
ROE(5y)11.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.52%
GM growth 5Y0.92%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.13
Cap/Depr 77.12%
Cap/Sales 6.99%
Interest Coverage N/A
Cash Conversion 29.02%
Profit Quality N/A
Current Ratio 3.44
Quick Ratio 2.01
Altman-Z 3.91
F-Score6
WACC11.5%
ROIC/WACCN/A
Cap/Depr(3y)128.04%
Cap/Depr(5y)168.75%
Cap/Sales(3y)8.98%
Cap/Sales(5y)11.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.43%
EPS 3Y-63.57%
EPS 5Y-24.39%
EPS Q2Q%-277.78%
EPS Next Y-390.55%
EPS Next 2Y-104.81%
EPS Next 3Y66.75%
EPS Next 5YN/A
Revenue 1Y (TTM)2.92%
Revenue growth 3Y-3.62%
Revenue growth 5Y8.41%
Sales Q2Q%-6.29%
Revenue Next Year-2.01%
Revenue Next 2Y2.12%
Revenue Next 3Y6.38%
Revenue Next 5YN/A
EBIT growth 1Y-117.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year368.82%
EBIT Next 3Y132.51%
EBIT Next 5YN/A
FCF growth 1Y54.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.28%
OCF growth 3Y-48.63%
OCF growth 5Y-13.79%

ALPHA & OMEGA SEMICONDUCTOR / AOSL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALPHA & OMEGA SEMICONDUCTOR?

ChartMill assigns a fundamental rating of 3 / 10 to AOSL.


What is the valuation status of ALPHA & OMEGA SEMICONDUCTOR (AOSL) stock?

ChartMill assigns a valuation rating of 1 / 10 to ALPHA & OMEGA SEMICONDUCTOR (AOSL). This can be considered as Overvalued.


Can you provide the profitability details for ALPHA & OMEGA SEMICONDUCTOR?

ALPHA & OMEGA SEMICONDUCTOR (AOSL) has a profitability rating of 2 / 10.